安捷伦科技(NYSE:A)CEO减持911股股票——MarketBeat报道
Insider Selling: Agilent Technologies (NYSE:A) CEO Sells 911 Shares of Stock - MarketBeat
生物技术与制药领域的最新动态
Insider Selling: Agilent Technologies (NYSE:A) CEO Sells 911 Shares of Stock - MarketBeat
The Ensign Group, Illumina, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know - MSN
Mettler-Toledo, Agilent, Waters Corporation, Merck, and Regeneron Shares Skyrocket, What You Need To Know - MSN
Mettler-Toledo, Agilent, Waters Corporation, Merck, and Regeneron Shares Skyrocket, What You Need To Know - Yahoo Finance
Waters Corporation: Launching A Bioseparations Power Surge With Breakthrough Large-Molecule Innovations! - Smartkarma
Bruker, 10x Genomics, PacBio, ICU Medical, and Dentsply Sirona Shares Skyrocket, What You Need To Know - TradingView
P/E Ratio Insights for Agilent Technologies - Agilent Technologies (NYSE:A) - Benzinga
Top Makary aide Jain-Nagpal remains at the FDA after White House pushback
10X Genomics stock hits 52-week high at 17.7 USD By Investing.com - Investing.com Nigeria
AstraZeneca to onshore rare disease portfolio as part of its $50B pledge to the US
Teva loses IRA drug pricing challenge in DC federal court
Deal Dispatch: Abbott, TPG And Lonza Make Major Moves, M&M Custard And New Fortress Energy Struggle - Benzinga
Why Is Thermo Fisher (TMO) Up 0.2% Since Last Earnings Report? - Yahoo Finance
Sarepta ends Elevidys trial with Hansa's pre-treatment; Some pipeline cuts at Moderna
FDA investigates child death potentially related to Takeda's enzyme replacement therapy
Novo, Lilly begin to sell obesity medications directly to employers
Roche inks $200M pact for Freenome's cancer screening blood test - Fierce Biotech
Lilly becomes first $1 trillion pharma company
Contineum's J&J-partnered drug fails Phase 2 multiple sclerosis trial
Hikari Tsushin Inc. Raises Stock Holdings in Agilent Technologies, Inc. $A - MarketBeat